Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yep, despite the poor entry point, I'm staying in until the end of March at a minimum. Too much upside from here imo.
Sure, but damn if it doesn't suck to see your basis get wiped out on bullshit.
If they both wanna go to $50, I guess I’ll take it....
I’m so sick of their co-dependence
Federal funding can be means-tested, but generally awards aren’t contingent on future events; either you qualify or you do not at the time of application or as specified by whatever deadline is defined.
I don’t think this has anything to do with BARDA, at least based on information we currently have. That award is meant to accelerate bringing promising drugs to availability for the public good, not profitability for the company per-se.
If HGEN expands into other markets, it’ll need capital to do so. Frankly, if the share price increases substantially, they’d be silly not to sell shares to get them to sustainability.
So far, I haven’t seen a company dramatically succeed after the Cantor funding, but again none of them had multi-billion dollar products (imo).
He doesn't mess around when it's "THE BIG ONE", lol!
So, I decided to do a little more digging on the Cantor Controlled Equities Offering (otherwise noted as a ATM offering).
Here are three companies that engaged with this type of equity raise since 2016:
PGNX - Progenics Pharmaceuticals, Inc.
https://fintel.io/doc/sec-pgnx-progenics-pharmaceuticals-ex11-2017-january-06-18459-458
TRXC - TransEnterix, Inc.
https://www.sec.gov/Archives/edgar/data/876378/000129993316002027/htm_53091.htm
SPNE - SeaSpine Holdings
https://investor.seaspine.com/node/6491/html
In each case, the company was an emerging biotech that needed significant capital raise and was on the cusp of bringing a new drug(s) or product to market, the commission was 3%, the amounts were roughly 50-100 million dollars, the beginning share price was in the teens or low 20s, and overall the terms were very similar.
In each case, the companies' share prices remained flat or fell over a significant period (+1 year). In all cases, there were additional capital raises, or in the case of PGNX, a merger down the road (LNTH - Lantheus).
None of the companies death-spiraled and are all still healthy today. This is a dilutive agreement, but the actual impact is quite small. The fact each of these companies had to seek additional equity raise signals that there were unable to transition effectively to commercialization, which is where I believe Humanigen will differ.
This is very much an initial investigation to help provide a small amount of information. As always, there is context to consider, and frankly none of the products from these companies were as necessary as I believe Lenzilumab to be.
However, I believe in being thorough. If anyone else has any thoughts or research on this, please share.
Hey, I’m working on 2021 to have plenty of spare cash to yolo with you!
Don’t worry, there’s plenty of money coming!
lol, I'll sit this one out. I hope it goes bonkers for you!
Amazing hold so far. I sold more than 90k shares from $.93s at $2.73 and happily walked away.
If you guys can pocket at $5 or greater, then I salute all of you sirs!
Unfortunately it's still a bit of a guessing game.
But I'm certainly more intrigued than I was even the last couple of months, but I want to follow through with HGEN for now.
GME and ATOM are going to become the start of my longer-term holds for sure!
I couldn't agree more.
If I knew he was going to take over for sure, I'd pour every cent I have into GME and happily sit and wait.
You are the yolo king!
Agreed. They need serious price advancement, create a small secondary offering, and use that cash to wipe their debt and clean up the books.
It's very possible if an investor like ARK causes a massive price rush. Even if the price fell 50% on an offering news, it'll bounce back as BNGO executes over the next several years.
Long-term investment if you're willing to tolerate short-term turbulence.
I'm definitely going to put her on my radar from now on. You can't argue with results!
You know, it’s interesting that you bring up investing “above your pay grade”. I was always told to only invest in things I fully understood, but I came to the realization that no one really understands disruptive tech.
It’s far better to build out a network of people who understand different sectors, and then follow the discussions + market trends.
Since then, I’ve done far better than relying on my own expertise.
If only we could trade one day in the future lol!
Eh, don’t blame you one bit. I rotated out a 3rd into other stocks in the move, but I’m holding most of it for Jan/Feb.
Eyes on the prize!
Guys, I appreciate the discussion, but this is quickly becoming a CYDY discussion.
Let’s get back on topic with how rich HGEN is going to make us!
The race certainly is on!
Merry Christmas!
Merry Christmas everyone!
Man, it’s tough being this wrong and yet this self-assured.
I know!
Had to have some cash in both! I can’t predict a short squeeze and then not profit at all!
I had to hop $12k from HGEN to GME. Most of my cash in HGEN, but I can’t afford to have 0 exposure to a potential short squeeze!
GME back in front, lol!
I can’t believe it’s taking off at the same damn time as HGEN...
FFS.
GME pissing me off again!
Stop trying to catch HGEN!!!
Finally, HGEN is taking the lead!!!
Huh? What?
Yes, it should. That’s why it’s a minimum.
People should be looking for the $30s at a minimum.
I think we’ll go much higher over the course of next year, and I’m happy to hold a lot of shares to go long-term gains unless we get a crazy pop to $100.
It was a t-trade. It occurred throughout the day (or in a lump amount) "off-the-books" and recorded at the end.
It's so damn irritating.
Part of the reason I want HGEN to pop to 100 is I want to sell everything and immediately put it into GME, but GME won't just stop for a fucking month or so and chill.
Love the CYDY idiots showing up. Must feel bad betting on the wrong horse.
LOL, get the fuck outta here!
Strong base!
Stop dreaming, and invest in HGEN right now.
0.06 is decent for statistical significance. 0.05 is not a hard rule, and anyone using it that way is a moron.
All the rats come out on a red day, lol.
Holy shit that's fast!
Which we had until freaked out over vaccine news...oops.